Home News About us Comitato scientifico Iscriviti Utenti Etica Contenuti Guida Faq Stage Contatti
Logo Pharmamedix
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Sibutramina

Bibliografia - Quali fonti bibliografiche per Sibutramina?

1. Appolinario J.C. et al., J. Clin. Psychiatry, 2002, 63 (1), 28.

2. Aronne L.J. et al., Obesity (Silver Spring), 2010, consultabile on line all’indirizzo: http://www.ncbi.nlm.nih.gov/pubmed/20094043

3. Bae S.K. et al., Drug Metab. Dispos., 2008, 36 (8), 1679.

4. Bailey D.G., Dresser G.K., Am. J. Cardiovasc. Drugs, 2004, 4 (5), 281.

5. Bray G.A. et al., Obes. Res., 1999, 7 (2), 189.

6. Canadian Adverse Reaction Newsletter, 2003, 13 (3), 3.

7. Chung J.Y. et al., J. Clin. Pharmacol., 2010, consultabile on line all’indirizzo: http://www.ncbi.nlm.nih.gov/pubmed/20350955

8. Cole J.O. et al., J. Clin. Psychopharmacol., 1998, 18 (3), 231.

9. Coletta D.K. et al., Diab. Vasc. Dis. Res., 2006, 3 (3), 186.

10. Dahlin A., Beermann B., Eur. J. Clin. Pharmacol., 2007, 63 (2), 205.

11. Daniels S.R. et al., Pediatrics, 2007, 120 (1), e147.

12. Derosa G. et al., Metabolism, 2010, consultabile on line all’indirizzo: http://www.ncbi.nlm.nih.gov/pubmed/20423740

13. De Santis M. et al., Drug Saf., 2006, 29, 255.

14. Einarson A. et al., Eur. J. Obstet. Gynecol. Reprod. Biol., 2004, 116, 112.

15. EMEA, 2010, “Questions and answers on the suspension of medicines containing sibutramine” consultabile on line all’indirizzo: http://www.ema.europa.eu/pdfs/human/referral/sibutramine/Sibutramine_Q&A_80817909en.pdf

16. Ernest D. et al., Ann. Pharmacother., 2008, 42 (10), 1514.

17. Esposito P. et al., Am. J. Kidney Dis., 2008, 52 (1), 137.

18. Faria A.N. et al., Arq. Bras. Cardiol., 2002, 78 (2), 172.

19. FDA, 2010, “Follow-Up to the November 2009 Early Communication about an Ongoing Safety Review of Sibutramine, Marketed as Meridia” consultabile on line all’indirizzo: http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/ucm198206.htm

20. Fu P.K. et al., Neurologist, 2010, 16 (2), 129.

21. Gazdag G., Szabó Z., Neuropsychopharmacol. Hung., 2008, 10 (2), 107.

22. Gokcel A. et al., J. Endocrinol. Invest., 2002, 25 (2), 101.

23. Gokcel A. et al., Diabetes Obes. Metab., 2002a, 4 (1), 49.

24. Halpern A. et al., Rev. Hosp. Clin. Fac. Med. Sao Paulo, 2002, 57 (3), 98.

25. Hanotin C. et al., Obes. Res., 1998, 6 (4), 285.

26. Hansen D.L. et al., Int. J. Obes. Metab. Disord., 1999, 23 (10), 1016.

27. Hansen D.L. et al., Am. J. Clin. Nutr., 1998, 68 (8), 1180.

28. Hansen H.H. et al., Eur. J. Pharmacol., 2010, consultabile on line all’indirizzo: http://www.ncbi.nlm.nih.gov/pubmed/20385125

29. Harrison-Woolrych M. et al., Br. J. Clin. Pharmacol., 2006, 61 (4), 464.

30. Heal D.J. et al., Int. J. Obes. Metab. Disord., 1998, 22 Suppl. 1, S18.

31. James W.P. et al., Lancet, 2000, 356, 2119.

32. Jones S.P., et al., Int. J. Obes., 1995, 19 Suppl. 2, 41.

33. Jones S.P. et al., Int. J. Obes., 1996, 20 Suppl.4, Abst 20-251-FP3.

34. Kadioglu M. et al., Birth Defects Res. A Clin. Mol. Teratol., 2004, 70, 545.

35. Kim K.A. et al., Clin. Pharmacol. Ther., 2009, 86 (5), 511.

36. Lee J. et al., J. Psychosom. Res., 2008, 64 (1), 107.

37. Luque C.A., Rey J.A., Ann. Pharmacother., 1999, 33 (9), 968.

38. McLaughlin T. et al., Metabolism, 2001, 50 (7), 819.

39. McMahon F.G. et al., J. Hum. Hypertens, 2002, 16 (1), 5.

40. Narkiewicz K., Int. J. Obes. Relat. Metab. Disord., 2002, 26 (Suppl. 4), S38.

41. Nisolo E., Carruba M.O., Obes. Rev., 2000, 1 (2), 127.

42. Reiser M. et al., Obes. Rev., 2010, 11 (4), 329.

43. Robert E et al., Reprod. Toxicol., 1995, 9, 57.

44. Rolls B.J. et al., Obes. Rev., 1998, 6 (1), 1.

45. Sari R. et al., Clin. Exp. Med., 2009, consultabile on line all’indirizzo: http://www.ncbi.nlm.nih.gov/pubmed/19937362

46. Seebeck J. et al., Int. J. Clin. Pharmacol. Ther., 2008, 46 (7), 375.

47. Serrano-Rios M. et al., Diabet. Med., 2002, 19 (2), 119.

48. Sood A. et al., Nicotine Tob. Res., 2009, 11 (12), 1479.

49. Sramek J.J. et al., J. Hum. Hypertens., 2002, 16 (1), 13.

50. Starling R.D. et al., Obes. Res., 2001, 9 (4), 251.

51. Tallett A.J. et al., Behav. Brain Res., 2010, 207 (1), 174.

52. Wadden T.A. et al., Obes. Res., 2000, 8 (6), 431.

53. Wesnes K.A. et al., Br. J. Clin. Pharmacol., 2000, 49 (2), 110.

54. Wilfley D.E. et al., Am. J. Psychiatry, 2008, 165 (1), 51.

55. Wirth A., Krause J., JAMA, 2001, 286 (11), 1331.

56. Zannad F. et al., Am. Heart J., 2002, 144 (3), 508.